Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Maplight Therapeutics Inc.

United States 800 Chesapeake Drive, 94063-4748, United States

About the sponsor

Maplight Therapeutics Inc. is focused on hallucinations and delusions associated with Alzheimer’s disease psychosis, with clinical research centered on symptoms that affect cognition, perception, and behavioral stability in this neuropsychiatric condition.

  • Hallucinations
  • Delusions
  • Neuropsychiatric symptoms

The sponsor’s current research activity is directed toward treatment options for symptom relief in Alzheimer’s disease-related psychosis across multiple collaborating sites.

About Specializations

Maplight Therapeutics Inc. runs clinical trials in conditions such as Dementia of the Alzheimer's type with delusions, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Dementia of the Alzheimer's type with delusions

Recruiting
InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE
  • Sponsor:Maplight Therapeutics Inc.

Dementia of the Alzheimer's type with delusions

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE
  • Sponsor:Maplight Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.